News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|February 11, 2017

Liver Cancer: What's On the Horizon?

Newsletter

Stay up to date on cancer updates, research and education

Related Content

MRI

Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer

December 11th 2025

Enhertu and Perjeta led to better quality-of-life and less side effects than standard-of-care among patients with HER2+ advanced or metastatic breast.

Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer

December 11th 2025

Image of ribbons.

Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer

December 11th 2025

ovarian failure

Checkpoint Inhibitors May Impact Fertility in Early TNBC Treatment

December 11th 2025

Verzenio showed meaningful improvement for some patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 treatment: © stock.adobe.com.

Verzenio Offers Potential Benefit After Prior Therapy in HR+/HER2– Breast Cancer

December 11th 2025

Trending on CURE

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

Giredestrant Improves Outcomes in ER+/HER2– Breast Cancer

A Closet Full of Boobs and the Thought That Caught Me by Surprise

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

Trodelvy Not Associated With Significant Progression Improvements in HR+/HER2– mBC

© 2025 MJH Life Sciences^®

All rights reserved.